Serum phospholipase A2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shock
Authors:
- K. ScottK. Scott
- G. SmithGSG. Smith
- I. RajkovicIRI. Rajkovic
- E. StefanskiESE. Stefanski
- B.D. SchoutenBSB.D. Schouten
- R. SinghRSR. Singh
- W. PruzanskiWPW. Pruzanski
- 1 January 1992
- journal article
- Published by Elsevier in Life Sciences
- Vol. 50 (11) , 807-811
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Letʼs agree on terminologyCritical Care Medicine, 1991
- Extracellular phospholipase A2 secretion is a common effector pathway of interleukin-1 and tumour necrosis factor actionImmunology Letters, 1991
- A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbitsThe FASEB Journal, 1991
- Compartmental heterogeneity of soluble phospholipases AInflammation, 1990
- Release of phospholipase A2 activity from rat vascular smooth muscle cells mediated by cAMPEuropean Journal of Biochemistry, 1989
- Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.Journal of Clinical Investigation, 1988
- Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.Journal of Clinical Investigation, 1988
- Pathogenesis of hypotension in septic shockCritical Care Medicine, 1988
- Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemiaNature, 1987
- Involvement of circulating phospholipase A2 in the pathogenesis of the hemodynamic changes in endotoxin shockCanadian Journal of Physiology and Pharmacology, 1983